US Rare Earth Prices: A New Tool for Strategic Independence
- 85-90%: China's control of global rare earth processing
- 75%: Reduction in magnet exports after China's 2025 export controls
- $439 million: US DoD investment since 2020 to re-shore rare earth supply chain
Experts agree that the introduction of independent US rare earth pricing is a critical step toward reducing strategic dependence on China and securing domestic supply chains for key industries.
US Rare Earth Prices: A New Tool for Strategic Independence
HOUSTON, TX – December 11, 2025 – In a market long defined by opacity and geopolitical risk, a significant move toward transparency has just been made. Global commodity intelligence firm Argus has launched the first-ever suite of delivered US rare earth oxide prices, a development that extends far beyond niche commodity trading. For industry leaders across the automotive, defense, and even medical technology sectors, this new pricing framework represents a critical tool in the high-stakes effort to build resilient, domestic supply chains and reduce strategic dependence on foreign powers.
The announcement arrives at a pivotal moment, directly responding to a series of aggressive export controls imposed by China throughout 2025. By providing independent, verifiable price points for seven critical rare earth oxides, Argus is shedding light on a market that has become a central battleground in the global competition for technological and economic supremacy.
The Geopolitical Catalyst
The strategic importance of this new pricing data cannot be understood without acknowledging the seismic shifts in the global rare earth landscape. China, which controls an estimated 85-90% of global rare earth processing, has increasingly leveraged its market dominance as a tool of statecraft. In April 2025, Beijing implemented export licensing requirements for several heavy rare earths, including dysprosium (Dy) and terbium (Tb)—elements indispensable for the high-performance magnets that power electric vehicle motors, wind turbines, and sophisticated missile guidance systems.
The situation escalated in October when the controls were expanded to include more elements and, crucially, rare earth processing technologies and magnet manufacturing equipment. These measures, justified by China on grounds of national security, effectively weaponized its control over the supply chain. The immediate impact was severe, with reports of a 75% reduction in magnet exports and analysts forecasting price spikes of up to 500% for certain materials. For Western manufacturers, the move was a stark reminder of a critical vulnerability that had been discussed for years but was now an undeniable reality. Premiums for non-Chinese materials soared, creating a chaotic and unpredictable procurement environment.
"After close engagement with US market participants across several important downstream sectors which rely on critical mineral and rare earths, we are pleased to improve transparency with the first comprehensive suite of independent prices that accurately reflect new market realities," said Argus Media chairman and chief executive Adrian Binks in the official announcement, highlighting the direct link between the new assessments and the fractured market.
America's Race for Supply Chain Sovereignty
Washington and the US private sector have not been idle observers. For the past several years, a concerted effort has been underway to construct a "mine-to-magnet" domestic supply chain. China's actions in 2025 simply added rocket fuel to these initiatives. The US Department of Defense (DoD) has committed over $439 million since 2020 to re-shore every stage of the rare earth value chain, from mining and separation to metallization and magnet manufacturing.
A cornerstone of this strategy is the public-private partnership with MP Materials, the operator of the Mountain Pass mine in California—the only active rare earth mine in the United States. The DoD has not only become a major shareholder through a $400 million equity investment but has also guaranteed a 10-year offtake agreement with a price floor for neodymium-praseodymium (NdPr) oxide, effectively de-risking the company's billion-dollar expansion. MP Materials is now on track to scale US magnet production tenfold by 2028, with its Fort Worth, Texas facility already beginning trial production of automotive-grade magnets.
This is complemented by other strategic investments, including over $288 million to Lynas USA for oxide production and new funding from the Department of Energy to develop recovery of rare earths from unconventional sources like e-waste. Policy frameworks like the Inflation Reduction Act (IRA) and the Defense Production Act (DPA) are creating powerful financial incentives, while defense regulations set to ban Chinese-origin magnets in US weapons systems by 2027 create a guaranteed market for domestic producers. The goal is ambitious but clear: achieve 75% magnet manufacturing independence by 2032.
Illuminating the Path for Industry
While government strategy sets the direction, it is market transparency that enables industry to execute. The new Argus prices for key oxides like NdPr, dysprosium, and terbium provide the reliable data points that procurement managers, financial officers, and supply chain strategists need to navigate this new terrain. Without independent benchmarks, companies are forced to negotiate in the dark, unable to accurately forecast costs, manage inventory, or make long-term investment decisions.
The impact will be felt across multiple critical sectors. For automakers rapidly transitioning to electric vehicles, stable and transparent pricing for magnet materials is essential for managing production costs and maintaining competitiveness. For the wind energy sector, it de-risks the massive capital investments required to build out renewable energy infrastructure.
Furthermore, the new assessments include yttrium oxide and gadolinium oxide, elements integral to applications in advanced ceramics and, significantly, medical imaging contrast agents. This underscores that supply chain security for critical minerals is not just an issue for heavy industry and defense; it directly impacts the healthcare and biopharmaceutical value chain. The ability to secure a stable supply of these materials at predictable prices is fundamental to innovation in diagnostics and advanced medical devices. By providing a clear, fortnightly price signal, Argus empowers these diverse industries to move beyond reactive crisis management and toward proactive, strategic sourcing.
This newfound transparency acts as a powerful incentive for further private investment. It provides the visibility needed for financiers to back new domestic mining and processing projects, knowing that a reliable pricing mechanism exists to value their output. It allows a downstream manufacturer to confidently sign a long-term offtake agreement with an emerging US supplier, building the ecosystem from the ground up. In this way, price reporting becomes more than just data; it becomes a foundational element of industrial policy and national security, fostering the very market it measures.
